Literature DB >> 19321606

Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing.

César G Albariño1, Eric Bergeron, Bobbie Rae Erickson, Marina L Khristova, Pierre E Rollin, Stuart T Nichol.   

Abstract

The New World arenaviruses, Junin, Machupo, Guanarito, Sabia, and Chapare, are associated with rapidly progressing severe hemorrhagic fever with a high rate of case fatality in various regions of South America. The threat of natural or deliberate outbreaks associated with these viruses makes the development of preventive or therapeutic measures important. Here we describe a Junin virus functional minigenome system and a reverse genetics system for production of infectious Junin virus. This robust, highly efficient system involves transfection of cells with only two plasmids which transcribe the virus S and L antigenomic RNAs. The utility of the system is demonstrated by generating Junin viruses which encode a glycoprotein precursor (GPC) containing the following: (i) the wild-type (SKI-1/S1P peptidase) cleavage site, (ii) no cleavage site, or (iii) a cleavage site where the SKI-1/S1P motif (RSLK) is replaced by a furin cleavage site (RRKR). In contrast to the wild-type virus, Junin virus lacking a GPC cleavage site replicated within successfully transfected cells but failed to yield infectious virus particles. This confirms observations with other arenaviruses suggesting that GPC cleavage is essential for arenavirus infectivity. In contrast, infectious Junin virus which encoded GPC cleaved by furin-like proteases was easily generated. The two-plasmid, high efficiency aspects of this Junin virus reverse genetics system show great promise for addressing important questions regarding arenavirus hemorrhagic fever disease and for development of precisely attenuated live arenavirus vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321606      PMCID: PMC2681955          DOI: 10.1128/JVI.00276-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Candid No. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in rhesus macaques.

Authors:  K T McKee; J G Oro; A I Kuehne; J A Spisso; B G Mahlandt
Journal:  Intervirology       Date:  1992       Impact factor: 1.763

2.  [ARGENTINE HEMORRHAGIC FEVER. I. PERIOD OF INCUBATION AND INVASION].

Authors:  H R RUGGIERO; A S PARODI; H G RUGGIERO; N METTLER; M BOXACA; A L DEGUERRERO; A CINTORA; C MAGNONI; H MILANI; F MAGLIO; C GONZALEZCAMBACERES; L ASTARLOA; G SQUASSI; D FERNANDEZ; V A GIACOSA
Journal:  Rev Asoc Med Argent       Date:  1964-05

3.  [Concerning the epidemic outbreak in Junin].

Authors:  A S PARODI; D J GREENWAY; H R RUGIERO; M FRIGERIO; J M DE LA BARRERA; N METTLER; F GARZON; M BOXACA; L GUERRERO; N NOTA
Journal:  Dia Med       Date:  1958-09-04

Review 4.  Toward a vaccine against Argentine hemorrhagic fever.

Authors:  J G Barrera Oro; K T McKee
Journal:  Bull Pan Am Health Organ       Date:  1991

5.  Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group.

Authors:  J I Maiztegui; K T McKee; J G Barrera Oro; L H Harrison; P H Gibbs; M R Feuillade; D A Enria; A M Briggiler; S C Levis; A M Ambrosio; N A Halsey; C J Peters
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

6.  Molecular characterization of attenuated Junin virus strains.

Authors:  C G Albariño; P D Ghiringhelli; D M Posik; M E Lozano; A M Ambrosio; A Sanchez; V Romanowski
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

7.  Heterogeneity and stability characteristics of Candid 1 attenuated strain of Junin virus.

Authors:  M Contigiani; S Medeot; G Diaz
Journal:  Acta Virol       Date:  1993-02       Impact factor: 1.162

8.  A novel mechanism for the initiation of Tacaribe arenavirus genome replication.

Authors:  D Garcin; D Kolakofsky
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

9.  Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.

Authors:  Thomas W Geisbert; Kathleen M Daddario-Dicaprio; Joan B Geisbert; Douglas S Reed; Friederike Feldmann; Allen Grolla; Ute Ströher; Elizabeth A Fritz; Lisa E Hensley; Steven M Jones; Heinz Feldmann
Journal:  Vaccine       Date:  2008-10-18       Impact factor: 3.641

10.  Prevalence of infection with Junin virus in rodent populations in the epidemic area of Argentine hemorrhagic fever.

Authors:  J N Mills; B A Ellis; J E Childs; K T McKee; J I Maiztegui; C J Peters; T G Ksiazek; P B Jahrling
Journal:  Am J Trop Med Hyg       Date:  1994-11       Impact factor: 2.345

View more
  47 in total

1.  Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP.

Authors:  Magali E Droniou-Bonzom; Therese Reignier; Jill E Oldenburg; Alex U Cox; Colin M Exline; Jessica Y Rathbun; Paula M Cannon
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

2.  Unpaired 5' ppp-nucleotides, as found in arenavirus double-stranded RNA panhandles, are not recognized by RIG-I.

Authors:  Jean-Baptiste Marq; Daniel Kolakofsky; Dominique Garcin
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

3.  Assembly of a functional Machupo virus polymerase complex.

Authors:  Philip J Kranzusch; Andreas D Schenk; Amal A Rahmeh; Sheli R Radoshitzky; Sina Bavari; Thomas Walz; Sean P J Whelan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-26       Impact factor: 11.205

4.  Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function.

Authors:  Eric Bergeron; César G Albariño; Marina L Khristova; Stuart T Nichol
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

5.  Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages.

Authors:  Xavier Carnec; Sylvain Baize; Stéphanie Reynard; Laure Diancourt; Valérie Caro; Noel Tordo; Michèle Bouloy
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

6.  Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.

Authors:  Jessica Y Rathbun; Magali E Droniou; Robert Damoiseaux; Kevin G Haworth; Jill E Henley; Colin M Exline; Hyeryun Choe; Paula M Cannon
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

7.  The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain.

Authors:  César G Albariño; Brian H Bird; Ayan K Chakrabarti; Kimberly A Dodd; Mike Flint; Eric Bergeron; David M White; Stuart T Nichol
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

8.  Junin virus infects mouse cells and induces innate immune responses.

Authors:  Christian D Cuevas; Madakasira Lavanya; Enxiu Wang; Susan R Ross
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

9.  Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (αβ/γ) receptor double knockout mice.

Authors:  Michael Patterson; Alexey Seregin; Cheng Huang; Olga Kolokoltsova; Jennifer Smith; Milagros Miller; Jeanon Smith; Nadezhda Yun; Allison Poussard; Ashley Grant; Bersabeh Tigabu; Aida Walker; Slobodan Paessler
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

10.  Cleavage of the Junin virus nucleoprotein serves a decoy function to inhibit the induction of apoptosis during infection.

Authors:  Svenja Wolff; Stephan Becker; Allison Groseth
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.